Granules India, a low profile small-cap Pharma company, has been put on the center stage by being proclaimed as a potential 100-bagger in the Motilal Oswal Wealth Creation Study report. We need to urgently come to grips with the stock because there may be mega bucks in store for us
When stock wizards Raamdeo Agrawal & Hiren Ved list out their favourite stocks, we need to listen in with rapt attention because there is a chance to make hefty profits
Centrum and IndiaNivesh have identified a stock each that they claim are quoting at “compelling attractive valuations” and have the potential for substantial gains
ICICIDirect has carefully studied the FY 2014 results of the top large-cap and mid-cap Pharma stocks and given clear-cut recommendations on what Pharma stocks investors should buy
Centrum has released a research report identifying 6 top-quality high-conviction stock picks. The picks are from diversified sectors such as Autos, Pharma, Industrial, etc. Also, there is a mix of large-cap and mid-cap stocks
MRPL’s surge of 17% today vindicates the stand of some savvy stock pickers that if you time your purchase, you can make quick and hefty gains. However, the larger issue is whether MRPL will meet the same fate as its OMC cousins
Centrum Equity Research has conducted a comprehensive analysis of the best pharma companies & picked those with 30% expected return
MRPL, which was a forgotten stock, has suddenly become a favourite amongst stock pickers with everyone calling it a “compelling investment bet”. What’s going on?
Recent Comments